- Home
- FLO vs ZLAB Comparison
FLO vs ZLAB Comparison
Compare FLO & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLO | ZLAB |
|---|---|---|
| Founded | 1919 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2000 | 2017 |
Fundamental Metrics
Financial Performance| Metric | FLO | ZLAB |
|---|---|---|
| Price | $8.30 | $17.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $13.67 | ★ $49.60 |
| AVG Volume (30 Days) | ★ 5.0M | 639.7K |
| Earning Date | 02-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 12.10% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $5,256,479,000.00 | $460,156,000.00 |
| Revenue This Year | N/A | $14.46 |
| Revenue Next Year | $0.67 | $29.47 |
| P/E Ratio | $20.50 | ★ N/A |
| Revenue Growth | 3.00 | ★ 15.33 |
| 52 Week Low | $8.18 | $15.96 |
| 52 Week High | $20.23 | $44.34 |
Technical Indicators
Market Signals| Indicator | FLO | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 28.33 | 39.87 |
| Support Level | N/A | $17.03 |
| Resistance Level | $9.03 | $19.71 |
| Average True Range (ATR) | 0.28 | 0.66 |
| MACD | -0.02 | -0.15 |
| Stochastic Oscillator | 9.96 | 12.22 |
Price Performance
Historical ComparisonAbout FLO Flowers Foods Inc.
Flowers Foods Inc operates as a producer and marketer of packaged bakery foods in the United States. Its principal products include breads, buns, rolls, snack items (bars, cakes, cookies, and crackers), bagels, English muffins, tortillas, and baking mixes. These products are sold under the brand names Nature's Own, Dave's Killer Bread (DKB), Canyon Bakehouse, Simple Mills, Wonder, and Tastykake. The company derives the majority of its revenue from the sales of its bakery products.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.